泚å°ãããªãæ¹ãã¹ã²ããã ããïŒïŒ#PRãªãžã¥ã©ã³ã®ãã¥ã¢ã«ãšãã§ã¯ãã¢ã³ãã«(ãŽãŒã«ãã¢ã³ãã«)ãã詊ãããŸããïŒèª¿ã¹ãŠã¿ãã30mlã§8,250åãæ®éã«é«ããŠèð±ææ©ããã³ã¹äŸ¡æ Œð±ã§ããïŒïŒäœ¿ã£ãŠã³ã£ããïŒïŒïŒå¡ã£ãåŽãããèãã«ãŒã³...
ãã£ãšèŠãããããã¢ã€ãã REJURANÃçŸå®¹æ¶²
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬190äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
REJURAN ã¿ãŒã³ãªãŒããŒã¢ã³ãã« | 2,728å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬106äœ | èã®è¡šé¢ãã€ãããšããŠããŠå€æ¹ã®ããã¿ãæ°ã«ãªãã«ãããªããŸããïŒ | 詳现ãèŠã | |
REJURAN ã¢ã€ã¹ãã£ãŒããªãŒãã¡ã³ãã¢ã³ãã« | 3,850å |
| ãã£ã¡ããšããã¯ãªã¢ãªãã¯ã¹ãã£ã èãªãã¿ãããã£ãïŒïŒïŒïŒãã£ã±ãããšæããããã£ããä¿æ¹¿ | 詳现ãèŠã |
çŸå®¹æ¶²ã©ã³ãã³ã°
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
SHISEIDO ã¢ã«ãã£ãã¥ãŒã³â¢ ãã¯ã©ã€ãžã³ã° ã»ã©ã | 9,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬12äœ | ã¹ã«ã¹ã«ã£ãšäŒžã³ãŠãèã«ãªãããšã»ãã®ããã€æãæããŸãã åŸèã¯ãããã | 詳现ãèŠã | |
DECORTà ãªããœãŒã ã¢ããã³ã¹ãããªãã¢ã»ã©ã | 12,650å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬13äœ | ããããªã£ãããŸã£ãèãæãããã»ãããŠããããããªã€ã¡ãŒãžã§ããïŒ | 詳现ãèŠã | |
SK-II ãžã§ãããã£ã¯ã¹ ãªãŒã© ãšãã»ã³ã¹ | 20,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬36äœ | ã·ãäºé²ã ãã§ãªãããã€ãäžããŠãããããã¡ãæŽããŠããã广ãïŒ | 詳现ãèŠã | |
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬190äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
Torriden ãã€ãã€ã³ ã»ã©ã | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬44äœ | èã«ã®ãããšããã«ã¹ããšéŠŽæã¿ãŸãã銎æããšãã¿ã€ãããããµã©ãµã©ã«ãªãïŒ | 詳现ãèŠã | |
ã© ããã·ã¥ ã㌠ãšãã¡ã¯ã© ããŒã«ã±ã¢ ã»ã©ã | 5,280å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬80äœ | ããããšãã¿ã®ãããã¯ã¹ãã£ãŒã§ã䌞ã³è銎æã¿å ±ã«âã¹ãšã€ããªããã©ãã£ãšãä¿æ¹¿ããŠãããŸãïŒ | 詳现ãèŠã | |
Anua ã¢ãŒã©ã€ã³é ž15 ã€ã³ãã³ã¹ã«ãŒãã³ã°ã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬112äœ | 軜ãããªãã¯ã¹ãã£ãŒã§çŽ æ©ãèã«éŠŽæã¿ã最ããããªäœ¿ãå¿å°ã§ãâš | 詳现ãèŠã | ||
ESTEE LAUDER ã¢ããã³ã¹ ãã€ã ãªã㢠SMR ã³ã³ãã¬ãã¯ã¹ | 12,100å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬69äœ | ããªãã§ããããªã¹ã¹ã¡ã®çŸå®¹æ¶²ã§ãâš | 詳现ãèŠã | |
Anua ããŒã¯ã¹ãããã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬34äœ | ä¿æ¹¿æåããã£ã·ããšé åãããŠããŠã ããäžæ¬ã§ããèããã£ãšããšããŸãâš | 詳现ãèŠã | ||
numbuzin 5çª çœçã°ã«ã¿ããªã³ïŒ£çŸå®¹æ¶² | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬19äœ | ãšãã¿ã®ãããã¯ã¹ãã£ãŒãªã®ã«ããããããªãðð» | 詳现ãèŠã |
ððð¢ ð»àŸàœ²ãã©ãã100âªâªâºïžâ¬âªããã®äººæ°ã¯ãã³ã
ãããããã¡ããã¡ããããã ä»ãŸã§ã¯ãã é ¬ã«è²ãã€ããããããããèªèããŠãªãã£ããã§ããã©ããã¯å¡ã£ãç¬éã«ãïŒãã¡ããã¡ãé ¬ãããïŒïŒã£ãŠãªããŸãã ãµããšå¡ãã ãã§ãã ãã£ãšè²ã¥ãããããªå¯æãé ¬ã«ããŠãããŠæ¬åœã«550åïŒïŒïŒïŒãšãªããŸãã 詊ããããäŸ¡æ Œãªã®ã§ãã²è³Œå ¥ããŠå®æããŠèŠãŠã»ããã§ãïŒããŒã¯å¯Ÿããèªèãå€ããŠãããã³ã¹ã¡ã§ãïŒïŒ
ãã£ãšèŠã120
1
- 5ã¶æå
ã©ããªãªããã®è²ã«ãåããããã ã¹ã«ã¹ã«ãšãããŠäœ¿ããããã§ãïŒïŒ ãã1æ¬ã§é¡ã®å°è±¡ãå€ãããŸããïŒ ãã¡ããã¡ãçããïŒïŒ ããã¯è²·ã£ãŠäœ¿ã£ãŠã¿ãªããšåãããªãã®ã§æ¯éè²·ã£ãŠäœ¿ã£ãŠã¿ãŠæ¬²ããã§ãïŒïŒïŒ
ãã£ãšèŠã113
4
- 5ã¶æå
ãšã€ãžã³ã°ã±ã¢ã©ã€ã³ãããã¹ãåç²§æ°Žãç»å ŽïŒ ããããåååŸ ã£ãŠãŸããïŒïŒ ã颚åäžããã«ãã䜿ãã¹ãã¬ãŒã¯ä»ãŸã§ã䜿ã£ãŠãŸããããšã€ãžã³ã°ã±ã¢ãåºæ¥ã¡ããã¹ãã¬ãŒã¯æ¬åœã«ãããããã§ãð¥²ð€ ãšã£ãŠãé«ä¿æ¹¿ã§ããããç§ãå¬ã«ãªã£ãŠããããã£ãšæŽ»èºããããªååã§ãïŒ
ãã£ãšèŠã101
1
- 2024.08.29
ã¢ã«ãã£ãã¥ãŒã³ã3/1ã«ãªãã¥ãŒã¢ã«ïŒ æ°ã«ãªãèæ©ã¿ ããã¿ã»æ¯ç©Žã»ããªã®ãªãã»å°ããã»ä¹Ÿç¥ã»èèã ããããèæ©ã¿ã«å¯Ÿå¿ïŒïŒ 䜿ãå§ããŠ2.3æ¥ç®ãããããæã®æŽé¡æã«èããã€ããšéããšæãå§ãã æã®æŽé¡åŸã®èãã€ãã»ããšã«ããã⊠ã€ããã€ããã«ãªã£ãŠãã¡ããã¡ãå¬ããã£ãã§ãâð€
ãã£ãšèŠã91
1
- 4ã¶æå
çŸå®¹æ¶²ããã£ã·ãå«ãã ããã¯ãµã€ãºã®ããããèã«å¯çããè±ããªæœ€ããäžããã¯ã€ãã¯ã«ãŒãã³ã°ããããå€éšã®åºæ¿ã«ããææã«ãªã£ãèããã£ãããšå ã¿èŸŒã¿ãèã®ãã¡ãæŽããªããåŒãç· ããŸãã ããã¯ãµãšãã¹é åã®ææèã®æ¹ã§ã䜿ãããããããããã¿ã€ãããã£ã±ãããŠããŸãã ãµã©ããšããŠããŠãšãŠã䜿ãããããããã¯åŸã¯ãã£ãšãã²ãããïŒãã¿ã€ãããšããªãã£ãã®ã§ã¡ã€ã¯åã«ã䜿ããããïŒ
ãã£ãšèŠã87
2
- 2024.08.13
èªç¶ç±æ¥ã®æåã§èã®ãã¡ãæŽããåŒãç· ããçŸå®¹æ¶²ãããã¯ãµãšãã¹(ä¿æ¹¿æå)100%é åã§ããã¡ãŒãžãåãææã«ãªã£ãèããã£ãšããšä¿æ¹¿ããèµ€ã¿ãæããŸãã ãã£ã±ããšãããã¯ã¹ãã£ãŒã§èã«çŽ æ©ã浞éããçŽ æ©ãæŽããŸãã ãµã©ããšããŠããŠãã¿ã€ããªãã®ã§å€å Žãæã®ã¡ã€ã¯åã«ã䜿ãããããšæããŸãã
ãã£ãšèŠã86
6
- 2024.08.13
åå詳现æ å ±REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã«
- ãã©ã³ãå
- REJURAN(ãªãžã¥ã©ã³)
- ã©ã³ãã³ã°IN
- å šäœã©ã³ãã³ã°å¹Žä»£å¥ã©ã³ãã³ã°è質å¥ã©ã³ãã³ã°
- 容éã»åèäŸ¡æ Œ
- 30ml: 8,250å
- åå説æ
- ãªãžã¥ã©ã³ã®ãªãªãžãã«PDRNãå ¥ã£ãŠããããªãã€çŸå®¹æ¶²ã c-PDRNâ»1 ããã€ã¢ã·ã³ã¢ããâ»2ããã¢ã«ãã³é žïŒ®ïœâ»2 ãã«ã³ãŸãŠæ ¹ãšãã¹â»3ãé åã è§è³ªå±€ãŸã§æœ€ããäžããèãªãºã ãæŽããâ»4ããšã§åŒŸåã®ããèæ¬æ¥ã®çŸãããžã ãªãžã¥ã©ã³æé«æè¡ã¹ããŒãšã€ãžã³ã°â»5äžèœçŸå®¹æ¶²ã â»1ãå æ°Žå解 : æŽèæå â»2ãé åç®çïŒä¿æ¹¿ â»3ãé åç®ç: æŽèæå â»4ãèããããã£ãŠããããããªç¶æ ã®ããš â»5ã幎霢ã«åãããã±ã¢ã®ããš
- ã¡ãŒã«ãŒå
- Pharma Research
- ã«ããŽãª
- ã¹ãã³ã±ã¢ã»åºç€åç²§å > çŸå®¹æ¶²
- æå
- ïŒ30mlïŒ æ°ŽãPEG-6ãã°ãªã»ãªã³ãã»ã€ãšãŠã€ãã€ããŽèãšãã¹ãBGãDPGããã€ã¢ã·ã³ã¢ããã1,2-ãããµã³ãžãªãŒã«ãã¢ããšãã©æ¶²æ±ãããŠãã³ã»ã³ã«è±ãšãã¹ãã«ã³ãŸãŠæ ¹ãšãã¹ãã¯ããã°ã¯æå®ãšãã¹ãããŒããã·ã¥ãã«ãŒããªãŒæå®ãšãã¹ãã«ã«ãããŒãã¹ã¯ã¯ã©ã³ãå æ°Žåè§£DNAãããµã³ã¿ã³ã¬ã ãæ°Žæ·»ã¬ã·ãã³ãã«ããªãªã«ã°ãªã³ãŒã«ããã¢ã«ãã³é žNaããšãã«ããã·ã«ã°ãªã»ãªã³ãããã·ã¬ã³ã°ãªã³ãŒã«ãããªãœã«ããŒã20ãã»ã©ããNPãã¢ããã·ã³ããã¬ãããŒã¹ãå°¿çŽ ããã³ãã¬ã³ã°ãªã³ãŒã«ãã¢ã«ããã³ãããµãããŒã«ãé ¢é žãã³ãã§ããŒã«ãã³ã¬ã¹ãããŒã«ãã»ãªã³ããªã¬ã€ã³é žãã©ãŠãªã«ã«ã«ããã³é žã€ããªã³ãã¢ã«ã®ã³é žNaããªã³é ž2Naãããªã¢ã¯ãªã«é žã°ãªã»ãªã«ããã«ã©ã³ããªã³é žK
ãã©ããŒãããŠããã ããŸããïŒãããããé¡ãããŸã(*ÂŽïž¶`)